MedPage Today (7/13, Grant) reports, “Opioid use disorder (OUD) treatment increased in Medicaid recipients from 2014 to 2018,” investigators concluded in an “analysis of Medicaid data from the 11 states that participated in the Medicaid Outcomes Distributed Research Network (MODRN) – Delaware, Kentucky, Maryland, Maine, Michigan, North Carolina, Ohio, Pennsylvania, Virginia, West Virginia, and Wisconsin.” That analysis “included six of the 10 states that ranked highest in the nation for overdose deaths.” The study revealed that “the proportion of people with opioid use disorder who received buprenorphine (Buprenex), methadone, or naltrexone (Revia) increased from 47.8% to 57.1% across that period.” The findings of the “exploratory serial cross-sectional study” were published June 13 in JAMA.
Related Links:
— MedPage Today (requires login and subscription)